Aditya Arora is bullish on Nifty Pharma, sees last leg of rally in high beta counters post Budget
Aditya Arora is tracking Nifty Pharma and mentions good moves in Cipla, Dr Lal Path Lab, and Metropolis. The chart structure of many pharma counters has improved. On the flip side, many financials or cyclical stocks appear to be topping out. Indiabulls Housing Finance is breaking out with volume support. Aditya Arora recommends buying it at Rs 215 with a stop loss at Rs 190 and a target of Rs 230 to 250.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
